Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
PCVX
PTGX
Add up to 3 more stocks
PCVX
Vaxcyte, Inc.
-9.82%
$66.57-7.25Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$9.61B
52W Range
$39.87 - $90.75
PTGX
Protagonist Therapeutics, Inc.
-1.38%
$138.69-1.94Delayed quote: Oct 6, 2026, 4:00 PM EDT
Market Cap
$8.92B
52W Range
$62.24 - $160.81
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 134.17 |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.49 | 10.60 |
| P/S Ratio | N/A | 31.63 |
| P/FCF Ratio | N/A | 68.30 |
| EV/EBITDA | N/A | 142.09 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 0.0% | 99.9% |
| Operating Margin | 0.0% | -343.6% |
| Net Margin | 0.0% | 29.4% |
| ROE | -38.6% | 9.8% |
| ROA | -33.9% | 9.4% |
| ROIC | -40.6% | 6.7% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 5.72 | 21.71 |
| Quick Ratio | 5.72 | 21.71 |
| Debt/Equity | 0.04 | 0.01 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.